
---
title: '圣达生物：公司生物素获韩国原料医药品登录证书'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=2783'
author: 证券时报网
comments: false
date: Mon, 01 Nov 2021 13:18:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=2783'
---

<div>   
<p>证券时报e公司讯，<a class="trsHotWords" href="http://info.stcn.com/dc/stock/?stockcode=SS603079" style="color: #2f67d1;text-decoration: none;" code="603079" target="_blank">圣达生物</a>(603079)消息，近日，根据韩国MSDF官网公告，<a class="trsHotWords" href="http://info.stcn.com/dc/stock/?stockcode=SS603079" style="color: #2f67d1;text-decoration: none;" code="603079" target="_blank">圣达生物</a>素已获得韩国原料医药品登陆证书，将对拓展韩国医药市场带来积极影响。</p>

                  
</div>
            